Compare Lucid Group Inc (LCID) vs Novo Nordisk A/S (NVO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lucid Group Inc vs Novo Nordisk A/S — how do they compare? Lucid Group Inc trades at $7.29 (market cap $2.77B), while Novo Nordisk A/S trades at $49.32 (market cap $220.53B). The key difference: Novo Nordisk A/S is far larger — about 79.6× Lucid Group Inc's market cap, and Novo Nordisk A/S pays a 3.63% dividend while Lucid Group Inc pays none. Which is the better fit depends on your goals.
| LCID | NVO | |
|---|---|---|
Market Cap | $2.77B | $220.53B |
Sector | Consumer Cyclical | Health |
52-Week High | $31.30 | $71.70 |
52-Week Low | $4.62 | $35.29 |
Enterprise Value | $5.24B | $239.49B |
Dividend Yield | — | 3.63% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lucid Group Inc
Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It is a vertically integrated company that designs, engineers, and builds electric vehicles, EV powertrains, and battery systems in-house using our own equipment and factory.
Read more on LCID →About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →
